March 6, 2019 NIAID Funding News
Read this full issue online at http://www.niaid.nih.gov/
Feature Articles
We lay out NIAID’s R01 and R21 application counts, award totals, success rates, and more over the past 20 years, considering these figures in relation to shifting NIH funding levels.
Opportunities and Resources
The Centers for Medical Countermeasures Against Radiation Consortium focuses on basic, translational, and applied studies with the goal of generating new medical products to assess and address damage caused by radiation exposure from a mass casualty incident.
NIAID will fund projects to conduct detailed characterization, direct comparisons, and further development of humanized immune system mouse models, particularly models that do not need to use fetal sources of human cells and tissue for immune reconstitution.
In The News
You can inform efforts to develop the next NIH Five-Year Strategic Plan for HIV/AIDS and Related Research for fiscal years 2021 through 2025.
NIH requires that foreign nongovernmental organizations funded under the President’s Emergency Plan for AIDS Relief agree to the terms and conditions of the Protecting Life in Global Health Assistance policy.
News Briefs
Advice Corner
Remember when planning the budget for your next renewal application that NIAID caps R01 renewal budgets at 20 percent over the direct costs of the last noncompeting award, excluding several categories of costs.
Reader Questions
New Funding Opportunities
- RFA-AI-19-029, Emerging Infectious Diseases Research Centers - Coordination Center (U01 Clinical Trial Not Allowed)
- RFA-AI-19-028, Emerging Infectious Diseases Research Centers (U01 Clinical Trial Not Allowed)
- PAR-19-209, Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
- PA-19-205, Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations--An ORWH FY19 Administrative Supplement (Admin Supp Clinical Trial Optional)
- RFA-AI-19-010, Limited Competition: Nonhuman Primate (NHP) Radiation Survivor Cohort (RSC) (U01 Clinical Trial Not Allowed
- HHS-NIH-NIAID-BAA2019-1, 2019 NIAID Omnibus Broad Agency Announcement
- PA-19-188, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)
- PA-19-191, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
- PA-19-192, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
- PA-19-195, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)
- PA-19-196, Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31)
- RFA-CA-19-044, Advancing Cancer Immunotherapy by Mitigating Immune-related Adverse Events (irAEs) (U01 Clinical Trial Not Allowed)
See other announcements at Opportunities & Announcements.
Send suggestions or comments to deaweb@niaid.nih.gov.
.png)
No hay comentarios:
Publicar un comentario